Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 9Colorectal Neoplasms 5Breast Neoplasms 5Neoplasms 4Small Cell Lung Carcinoma 3Lung Neoplasms 3Urinary Bladder Neoplasms 2Stomatitis 2Rectal Neoplasms 2Precancerous Conditions 2Male Urogenital Diseases 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Carcinoma, Non-Small-Cell Lung 2Vascular Diseases 1Ulcer 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Sexual Dysfunction, Physiological 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Non-melanoma Skin Cancer 1Neurotoxicity Syndromes 1Myocardial Ischemia 1

Interventions

Testosterone 2Laser Therapy 2Coconut Oil 2Water 1Vitamin E 1Transcranial Direct Current Stimulation 1Testosterone Propionate 1Sodium Chloride 1Replens 1Physical Therapy Modalities 1Fish Oils 1Fatty Acids, Omega-3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dyspareunia × Vitamin E × Clear all
NCT05129332 2024-04-04

Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia

Columbia University

Phase NA Withdrawn
Other

Dyspareunia, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡